These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 27352183)
1. The Transcriptome Study of Subtype M2 Acute Myeloblastic Leukemia. Wu AY; Yang HC; Lin CM; Wu BD; Qu QS; Zheng YH; Wei H; Mei XQ; Zeng ZH; Ma XD Cell Biochem Biophys; 2015 Jul; 72(3):653-6. PubMed ID: 27352183 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of AML 1/ETO fusion transcripts in patients with acute myelogenous leukemia. Cho EK; Bang SM; Ahn JY; Yoo SM; Park PW; Seo YH; Shin DB; Lee JH Korean J Intern Med; 2003 Mar; 18(1):13-20. PubMed ID: 12760263 [TBL] [Abstract][Full Text] [Related]
3. Relationships between AML1-ETO and MLL-AF9 fusion gene expressions and hematological parameters in acute myeloid leukemia. Muddathir ARM; Hamid TAM; Mohamed Elamin E; Khabour OF Gulf J Oncolog; 2020 Sep; 1(34):65-69. PubMed ID: 33431365 [TBL] [Abstract][Full Text] [Related]
4. Definition of a small core transcriptional circuit regulated by AML1-ETO. Stengel KR; Ellis JD; Spielman CL; Bomber ML; Hiebert SW Mol Cell; 2021 Feb; 81(3):530-545.e5. PubMed ID: 33382982 [TBL] [Abstract][Full Text] [Related]
5. [Correlations Between Wang XM; Ye YX; Yang L; Lu XJ; Ying BW Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):931-935. PubMed ID: 28598127 [TBL] [Abstract][Full Text] [Related]
6. [Expression of AML1/ETO9a isoform in acute myeloid leukemia-M2 subtype]. Miao YQ; Chen ZX; He J; Cen JN; Bao XJ; Qiu QC; Zhang DE; Yan M Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):27-9. PubMed ID: 17649722 [TBL] [Abstract][Full Text] [Related]
7. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia. Vangala RK; Heiss-Neumann MS; Rangatia JS; Singh SM; Schoch C; Tenen DG; Hiddemann W; Behre G Blood; 2003 Jan; 101(1):270-7. PubMed ID: 12393465 [TBL] [Abstract][Full Text] [Related]
8. Pontin is a critical regulator for AML1-ETO-induced leukemia. Breig O; Bras S; Martinez Soria N; Osman D; Heidenreich O; Haenlin M; Waltzer L Leukemia; 2014 Jun; 28(6):1271-9. PubMed ID: 24342949 [TBL] [Abstract][Full Text] [Related]
10. AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1. Nishida S; Hosen N; Shirakata T; Kanato K; Yanagihara M; Nakatsuka S; Hoshida Y; Nakazawa T; Harada Y; Tatsumi N; Tsuboi A; Kawakami M; Oka Y; Oji Y; Aozasa K; Kawase I; Sugiyama H Blood; 2006 Apr; 107(8):3303-12. PubMed ID: 16380455 [TBL] [Abstract][Full Text] [Related]
11. [GATA-2 gene overexpression and its clinical significance in acute myeloid leukemia with AML1/ETO fusion gene]. Xie HM; Gao L; Wang N; Xu YY; Li YH; Yu L; Wang LL Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 45(4):664-9. PubMed ID: 25286696 [TBL] [Abstract][Full Text] [Related]
12. [Detection of aml-1/eto fusion gene in patients with acute myeloid leukemia by real-time quantitative RT-PCR]. Jiang YM; Yuan H; Liu XY; Wang B; Li SJ; Wang N Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):17-22. PubMed ID: 19236739 [TBL] [Abstract][Full Text] [Related]
13. AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia. Fu L; Huang W; Jing Y; Jiang M; Zhao Y; Shi J; Huang S; Xue X; Zhang Q; Tang J; Dou L; Wang L; Nervi C; Li Y; Yu L FEBS J; 2014 Feb; 281(4):1123-31. PubMed ID: 24314118 [TBL] [Abstract][Full Text] [Related]
14. Recurrence of acute myelogenous leukemia with the same AML1/ETO breakpoint as at diagnosis after complete remission lasting 15 years: analysis of stored bone marrow smears. Tsukamoto N; Karasawa M; Tanaka Y; Yokohama A; Uchiumi H; Matsushima T; Murakami H; Nojima Y Int J Hematol; 2003 Nov; 78(4):362-9. PubMed ID: 14686496 [TBL] [Abstract][Full Text] [Related]
15. Combined use of interferon alpha-1b, interleukin-2, and thalidomide to reverse the AML1-ETO fusion gene in acute myeloid leukemia. Mi R; Chen L; Yang H; Zhang Y; Liu J; Yin Q; Wei X Ann Hematol; 2021 Oct; 100(10):2593-2601. PubMed ID: 34312685 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia. Huang S; Jiang MM; Chen GF; Qian K; Gao HH; Guan W; Shi JL; Liu AQ; Liu J; Wang BH; Li YH; Yu L Chin Med J (Engl); 2016 Jun; 129(11):1355-62. PubMed ID: 27231175 [TBL] [Abstract][Full Text] [Related]
17. The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice. Schessl C; Rawat VP; Cusan M; Deshpande A; Kohl TM; Rosten PM; Spiekermann K; Humphries RK; Schnittger S; Kern W; Hiddemann W; Quintanilla-Martinez L; Bohlander SK; Feuring-Buske M; Buske C J Clin Invest; 2005 Aug; 115(8):2159-68. PubMed ID: 16025155 [TBL] [Abstract][Full Text] [Related]
18. [Role of molecular screening for common fusion genes in the diagnosis and classification of leukemia]. Zhu YL; Zhang Y; Zhu P; Yang Y; Du JW; Liu J Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):236-9. PubMed ID: 15968309 [TBL] [Abstract][Full Text] [Related]
19. AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemia. Dunne J; Gascoyne DM; Lister TA; Brady HJ; Heidenreich O; Young BD Cancer Res; 2010 May; 70(10):3985-95. PubMed ID: 20460523 [TBL] [Abstract][Full Text] [Related]
20. [Frequency and clinical features of ASXL2 gene mutation in acute myeloid leukemia patients with AML1- ETO fusion gene positive]. Zhao JX; Chen XH; Li JL; Pan J; Tan YH; Xu ZF; Ren FG; Zhang YF; Xu J; Li MQ; Li J; Zhang N; Chang JM; Wang XJ; Wang HW Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):676-81. PubMed ID: 27587249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]